Is there a paradigm shift in use of microsomes and hepatocytes in drug discovery and development?

Authors

Sumit Basu Center for Pharmacometrics and Systems Pharmacology Department of Pharmaceutics University of Florida Orlando FL
Abdul Naveed Shaik Center for Pharmacometrics and Systems Pharmacology Department of Pharmaceutics University of Florida Orlando FL http://orcid.org/0000-0002-3672-2246

DOI:

https://doi.org/10.5599/admet.4.2.317

Keywords:

Microsomes, Hepatocytes

Abstract

Opinion

Downloads

Download data is not yet available.

Downloads

PDF

Published

29-06-2016

Issue

Vol. 4 No. 2 (2016)

Section

Opinions

How to Cite

Is there a paradigm shift in use of microsomes and hepatocytes in drug discovery and development?. (2016). ADMET and DMPK, 4(2), 114-116. https://doi.org/10.5599/admet.4.2.317

Download Citation

Similar Articles

Venkatesh Chunduri, Srinivas Maddi, Role of in vitro two-dimensional (2D) and three-dimensional (3D) cell culture systems for ADME-Tox screening in drug discovery and development: a comprehensive review , ADMET and DMPK: Vol. 11 No. 1 (2023)
Abdul Naveed Shaik, Changing trends in use of hepatocytes and microsomes for evaluating metabolism studies in drug discovery , ADMET and DMPK: Vol. 4 No. 2 (2016)
Vinod Anera Balakrishna, Anitha Police, Rakesh Hiremath, Anusha Raj, Suresh P Sulochana, Devaraj V Chandrasekhar, Zainuddin Mohd, Ravi Kanth Bhamidipati, Ramesh Mullangi, Preclinical assessment of ulixertinib, a novel ERK1/2 inhibitor , ADMET and DMPK: Vol. 5 No. 4 (2017)
Magesh Venkataraman, Gopi Chand Rao, Jeevan Karthik Madavareddi , Srinivas Rao Maddi, Leveraging machine learning models in evaluating ADMET properties for drug discovery and development , ADMET and DMPK: Vol. 13 No. 3 (2025)
Meiske Naomi Mamuaja, Tati Herlina, Rymond Jusuf Rumampuk, Iman Permana Maksum, Yaya Rukayadi, Flavonoids from Clerodendrum genus and their biological activities , ADMET and DMPK: Vol. 12 No. 6 (2024)
Jiang Pu, Jingsong He, Ru Xue, Ruiqi Gao, Yaoming Yu, Wanyong Feng, Pharmacokinetics and metabolism of ketoconazole after single ocular instillation in Sprague-Dawley rats , ADMET and DMPK: Vol. 12 No. 6 (2024)
Alka Singh, Ansab Akhtar, Prashant Shukla, Exploring hepatic stellate cell-driven fibrosis: therapeutic advances and future perspectives , ADMET and DMPK: Vol. 13 No. 4 (2025)
Jiang Pu, Mei Yang, Min Zhang, Ruiqi Gao, Yue Xiao, Lingyu Liu, Chuanjing Zhang, Wennuo Xu, Kaifang Li, Wanyong Feng, Elucidating CYP2D6-driven metabolism and hepatotoxic bioactivation of metoprolol in plateable human and animal hepatocytes , ADMET and DMPK: Vol. 13 No. 5 (2025)
Jenna L. Voellinger, Edward J. Kelly, Pharmacogenetic profiling and metabolic activity of human embryonic stem cell derived hepatocytes: focus on CYP450-mediated oxidation , ADMET and DMPK: Vol. 4 No. 2 (2016)
Alejandro Palacios, Javier Barberón, Patricio Leaden, Pedro Zeinsteger, Calendula officinalis L. (Asteraceae) possess antioxidant properties on Fe2+-initiated peroxidation of rat brain microsomes , ADMET and DMPK: Vol. 4 No. 2 (2016)

1-10 of 18 Next

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

Abdul Naveed Shaik, Sandeep Kumar Vishwakarma, Aleem A Khan, Metabolism of six CYP probe substrates in fetal hepatocytes , ADMET and DMPK: Vol. 4 No. 2 (2016)
Abdul Naveed Shaik, Ansar Ali Khan, Physiologically based pharmacokinetic (PBPK) modeling and simulation in drug discovery and development , ADMET and DMPK: Vol. 7 No. 1 (2019)
Abdul Naveed Shaik, Changing trends in use of hepatocytes and microsomes for evaluating metabolism studies in drug discovery , ADMET and DMPK: Vol. 4 No. 2 (2016)
Sumit Basu, Abdul Naveed Shaik, Role of drug transporters in drug development: a qualitative and quantitative approach , ADMET and DMPK: Vol. 5 No. 2 (2017)